Women's Health Research Institute, H214-4500 Oak St, Vancouver, British Columbia V6H 3N1, Canada; Department of Pathology & Laboratory Medicine, University of British Columbia, Rm. G227 - 2211 Wesb...ROR
Women's Health Research Institute Vancouver British Columbia CanadaROR
The menstrual cycle is a critical indicator of women's health. Early prolonged secondary amenorrhea increases risks for morbidity and mortality. Menstrual cycle research in women with HIV is inconsistent and often lacks an adequate comparison sample. We aimed to determine whether women with HIV have a higher lifetime prevalence of amenorrhea and whether this is independently associated with HIV and/or other biopsychosocial variables.
Methods
With data from 2 established HIV cohorts, participants assigned female at birth were eligible if aged ≥16 years, not pregnant/lactating, and without anorexia/bulimia nervosa history. Amenorrhea was defined by self-reported history of (1) no menstrual flow for ≥12 months postmenarche not due to pregnancy/lactation, medications, or surgery or (2) early menopause or premature ovarian insufficiency. Multivariable logistic regression models explored biopsychosocial covariates of amenorrhea.
Results
Overall, 317 women with HIV (median age, 47.5 years [IQR, 39.2-56.4]) and 420 women without HIV (46.2 [32.6-57.2]) were included. Lifetime amenorrhea was significantly more prevalent among women with HIV than women without HIV (24.0% vs 13.3%). In the multivariable analysis, independent covariates of amenorrhea included HIV (adjusted odds ratio, 1.70 [95% CI, 1.10-2.64]), older age (1.01 [1.00-1.04]), White ethnicity (1.92 [1.24-3.03]), substance use history (6.41 [3.75-11.1]), and current food insecurity (2.03 [1.13-3.61]).
Conclusions
Nearly one-quarter of women with HIV have experienced amenorrhea, and this is associated with modifiable risk factors, including substance use and food insecurity. Care providers should regularly assess women's menstrual health and advocate for actionable sociostructural change to mitigate risks.
secondary amenorrhea HIV women prolonged early associations, HIV amenorrhea menstrual dysfunction immune status, Swann King Prior amenorrhea women living with HIV, menstrual irregularity HIV antiretroviral therapy, early prolonged amenorrhea HIV CD4 viral load, reproductive health women HIV menstrual function, Open Forum Infectious Diseases amenorrhea HIV 2024, HIV treatment menstrual cycle disruption risk factors, Kaida Loutfy HIV women menstrual health
PMID 39301109 39301109 DOI 10.1093/ofid/ofae493 10.1093/ofid/ofae493
Cite this article
Swann, S. A., King, E. M., Pang, D., Silva, M. A. P., Campbell, A. R., Prior, J. C., Loutfy, M., Kaida, A., Côté, H. C. F., & Murray, M. C. M. (2024). Associations of Early Prolonged Secondary Amenorrhea in Women With and Without HIV. Open forum infectious diseases, 11(9), ofae493. https://doi.org/10.1093/ofid/ofae493
Swann SA, King EM, Pang D, Silva MAP, Campbell AR, Prior JC, et al. Associations of Early Prolonged Secondary Amenorrhea in Women With and Without HIV. Open Forum Infect Dis. 2024;11(9):ofae493. doi:10.1093/ofid/ofae493
Swann, S. A., et al. "Associations of Early Prolonged Secondary Amenorrhea in Women With and Without HIV." Open forum infectious diseases, vol. 11, no. 9, 2024, pp. ofae493.
Related articles
Bone HealthHIV PopulationBone Mineral Density ImpactMenstrual Disturbances
Open Access
King EM et al., 2019·Open forum infectious diseases
Background Women living with HIV (WLWH) have higher rates of long-term amenorrhea (no flow for ≥12 months) than HIV-negative women. However, little is known about the consequences of amenorrhea for WLWH. Both amenorrhea and HIV are associated with lower areal bone mineral density (BMD); though the combined effect of both on BMD remains unclear. In this cross-sectional study we investigated whether prolonged amenorrhea adversely affects BMD among WLWH. Methods We investigated BMD (using a Hologic bone densitometer) and prolonged amenorrhea among WLWH and HIV-negative control women of similar socioeconomic backgrounds aged 19–68 in the CARMA cohort. Participants were stratified by HIV status and history of prolonged secondary amenorrhea defined as a self-reported absence of menses for at least one year in the past or present, occurring at age <45 years and not due to surgery, breastfeeding, pregnancy or hormonal contraception. Hip and spine Z-scores (ageand racestandardized BMD values) were compared between groups using linear models, followed by multivariable analysis of BMD-related factors. Results WLWH (N = 129) had significantly lower hip (mean±SD −0.4 ± 0.9 vs. 0.3 ± 1.1; P < 0.001) and spine (−0.5 ± 1.3 vs. 0.2 ± 1.3; P = 0.001) Z-scores vs. controls (N = 129). Multivariable linear regression found prolonged amenorrhea was independently related to lower hip (P = 0.01), but not spine (P = 0.94) BMD. Within WLWH, the effect of amenorrhea was also additive to that of HIV, with hip Z-scores of -0.8±0.9for those with amenorrhea vs. -0.3±0.8for those normally cycling (P = 0.01). Amongst WLWH, those with prolonged amenorrhea had higher rates of illicit substance use, smoking, chronic opioid therapy, hepatitis C viral infection, and poorer HIV viral control than those with normal menstruation. Conclusion These data suggest that WLWH having prolonged amenorrhea of ≥1 year’s duration are at increased risk for hip bone loss, a finding influenced by comorbid, HIV-associated conditions. Screening WLWH for menstrual history will allow early discovery of osteoporosis risk, and stimulate preventative measures to mitigate bone loss. No reported disclosures.